Living Cell Technologies Limited

LCT

Living Cell Technologies Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is focused on discovering and developing treatments for conditions, such as diabetes and Parkinson's disease. The company operates in both Australia and New Zealand, being the research and development and product development into living cell technologies. The firm's product candidate includes NTCELL, an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells targeting Parkinson’s disease. Choroid plexus cells are naturally occurring support cells for the brain and secrete cerebrospinal fluid (CSF), which contains a range of factors that support nerve cell functions and protective enzymes that are crucial for nerve growth and healthy functioning. In NTCELL, the porcine choroid plexus cells are coated with LCT's technology IMMUPEL to protect them from attack by the immune system. The firm has completed two clinical trials of NTCELL in Parkinson's disease.

Alara Resources Limited

AUQ

Alara Resources Ltd. operates as a mineral exploration company. The company is headquartered in Balcatta, Western Australia. The company went IPO on 2007-05-24. Its projects include Al Wash-hi Majaza Copper-Gold Project, Daris Copper-Gold Project, Awtad Copper-Gold Project, Mullaq Copper-Gold Project and Al Ajal Copper-Gold Project. Its Al Hadeetha Wash-hi Majaza Copper-Gold Project is located over 160 kilometers (km) south-west of the capital city Muscat, in the Sultanate of Oman. Its Daris Project consists of two high-grade copper mineralization within the 587 square kilometers (km2) Block 7 Exploration License. Its Awtad Project comprises an area of approximately 497 km2 (Block 8) and is located immediately adjacent to the Block 7 (Daris Copper-Gold Project). Its Mullaq Exploration License area is adjacent to the Wash-hi Exploration License. Its Al Ajal Prospect is located near the village of Al Ajal in the Taww area, near the northern coast of the Sultanate of Oman and about 65 km west of Muscat.

Bionomics Limited

BNO

Bionomics Ltd. is a clinical stage biopharmaceutical company. The firm is focused on developing allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with unmet medical needs. The firm operates in the drug development segment in Australia. The firm is advancing its lead drug candidate, BNC210, which is an oral, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). Its α7 Receptor Positive Allosteric Modulators (PAMs) pipeline is targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. The company also includes a pre-clinical CNS pipeline that has two earlier-stage small molecule discovery programs targeting ion channels and representing opportunities for clinical programs.

Argosy Minerals Limited

AGY

Argosy Minerals Ltd. develops and produces lithium, base metals, graphite, and related minerals. The company is headquartered in Perth, Western Australia. The firm has interest in the Rincon Lithium Project in Salta Province, Argentina and a 100% interest in the Tonopah Lithium Project in Nevada, United States. The Rincon Lithium Project comprises up to 2,794 hectares of Mining Titles and mining easement landholdings at the Salar del Rincon in Salta Province, Argentina. The Project is located in the elevated and arid Puna region of Argentina and forms part of a number of highly mineralized salars in production and development. The Company’s Tonopah Lithium Project is located within the Big Smokey Valley region in Nevada, United States, and comprises 425 claims covering an area of approximately 34.25 square kilometers (km2). The Tonopah Lithium Project is directly analogous to the neighboring Silver Peak Lithium Mine deposit model, both geologically and structurally.